Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1983 Nov 1;129(9):969–974.

Acute graft-versus-host disease after allogeneic bone marrow transplantation.

C Perreault, M Gyger, J Boileau, Y Bonny, S Cousineau, M Lacombe, R Lavallee, E Tawil, G D'Angelo
PMCID: PMC1875857  PMID: 6367917

Abstract

In 25 patients receiving allogeneic bone marrow transplants methotrexate was used to prevent acute graft-versus-host disease (GVHD). Acute GVHD, grades 2 to 4, developed in only 5 (20%) of the patients. The incidence of acute GVHD in other series of recipients of bone marrow transplants has ranged from 5% to 76%. A review of the literature suggests that this variation cannot be completely accounted for by age, type of disease treated by transplantation or type of GVHD prophylaxis. However, transfusion of allogeneic lymphocytes that have not been completely inactivated by irradiation (e.g., in platelet and granulocyte preparations) and inadequate isolation-decontamination procedures may increase the probability of GVHD following bone marrow transplantation.

Full text

PDF
973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett M., Hand A. S. Effect of irradiated mouse spleen cells on severity of graft-versus-host disease. Transplantation. 1978 Sep;26(3):199–200. [PubMed] [Google Scholar]
  2. Beschorner W. E., Saral R., Hutchins G. M., Tutschka P. J., Santos G. W. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med. 1978 Nov 9;299(19):1030–1036. doi: 10.1056/NEJM197811092991902. [DOI] [PubMed] [Google Scholar]
  3. Button L. N., DeWolf W. C., Newburger P. E., Jacobson M. S., Kevy S. V. The effects of irradiation on blood components. Transfusion. 1981 Jul-Aug;21(4):419–426. doi: 10.1046/j.1537-2995.1981.21481275998.x. [DOI] [PubMed] [Google Scholar]
  4. Camitta B. M., Thomas E. D., Nathan D. G., Gale R. P., Kopecky K. J., Rappeport J. M., Santos G., Gordon-Smith E. C., Storb R. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979 Mar;53(3):504–514. [PubMed] [Google Scholar]
  5. Curtis J. E., Messner H. A. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility. Can Med Assoc J. 1982 Mar 15;126(6):649–655. [PMC free article] [PubMed] [Google Scholar]
  6. Doney K. C., Weiden P. L., Storb R., Thomas E. D. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients. Transplantation. 1981 Feb;31(2):141–143. doi: 10.1097/00007890-198102000-00015. [DOI] [PubMed] [Google Scholar]
  7. Epstein R. J., McDonald G. B., Sale G. E., Shulman H. M., Thomas E. D. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology. 1980 Apr;78(4):764–771. [PubMed] [Google Scholar]
  8. Filipovich A. H., McGlave P. B., Ramsay N. K., Goldstein G., Warkentin P. I., Kesey J. H. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet. 1982 Jun 5;1(8284):1266–1269. doi: 10.1016/s0140-6736(82)92840-9. [DOI] [PubMed] [Google Scholar]
  9. Gluckman E., Barrett A. J., Arcese W., Devergie A., Degoulet P. Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.). Br J Haematol. 1981 Oct;49(2):165–173. doi: 10.1111/j.1365-2141.1981.tb07212.x. [DOI] [PubMed] [Google Scholar]
  10. Glucksberg H., Storb R., Fefer A., Buckner C. D., Neiman P. E., Clift R. A., Lerner K. G., Thomas E. D. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974 Oct;18(4):295–304. doi: 10.1097/00007890-197410000-00001. [DOI] [PubMed] [Google Scholar]
  11. Herzig G. P., Graw R. G., Jr Granulocyte transfusion for bacterial infections. Prog Hematol. 1975;9:207–228. [PubMed] [Google Scholar]
  12. Hows J. M., Palmer S., Gordon-Smith E. C. Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia. Transplantation. 1982 Apr;33(4):382–386. doi: 10.1097/00007890-198204000-00008. [DOI] [PubMed] [Google Scholar]
  13. Korngold R., Sprent J. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev. 1983;71:5–29. doi: 10.1111/j.1600-065x.1983.tb01066.x. [DOI] [PubMed] [Google Scholar]
  14. Nusbacher J., Scher M. L., MacPherson J. L. Plateletpheresis using the haemonetics model 30 cell separator. Vox Sang. 1977 Jul;33(1):9–15. doi: 10.1111/j.1423-0410.1977.tb02230.x. [DOI] [PubMed] [Google Scholar]
  15. Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
  16. Prentice H. G., Blacklock H. A., Janossy G., Bradstock K. F., Skeggs D., Goldstein G., Hoffbrand A. V. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet. 1982 Mar 27;1(8274):700–703. doi: 10.1016/s0140-6736(82)92619-8. [DOI] [PubMed] [Google Scholar]
  17. Prevention and therapy of graft-versus-host disease. N Engl J Med. 1982 Aug 5;307(6):376–377. doi: 10.1056/NEJM198208053070616. [DOI] [PubMed] [Google Scholar]
  18. Ramsay N. K., Kersey J. H., Robison L. L., McGlave P. B., Woods W. G., Krivit W., Kim T. H., Goldman A. I., Nesbit M. E., Jr A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med. 1982 Feb 18;306(7):392–397. doi: 10.1056/NEJM198202183060703. [DOI] [PubMed] [Google Scholar]
  19. Ramsay N. K., Kim T., Nesbit M. E., Krivit W., Coccia P. F., Levitt S. H., Woods W. G., Kersey J. H. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood. 1980 Feb;55(2):344–346. [PubMed] [Google Scholar]
  20. Ringdén O., Lönnqvist B., Lundgren G., Gahrton G., Groth C. G., Möller E., Båryd I., Johansson B., Pihlstedt P., Gullbring B. Experience with a cooperative bone marrow transplantation program in Stockholm. Transplantation. 1982 May;33(5):500–504. doi: 10.1097/00007890-198205000-00007. [DOI] [PubMed] [Google Scholar]
  21. Santos G. W., Kaizer H. Bone marrow transplantation in acute leukemia. Semin Hematol. 1982 Jul;19(3):227–239. [PubMed] [Google Scholar]
  22. Seemayer T. A., Bolande R. P. Thymic involution mimicking thymic dysplasia: a consequence of transfusion-induced graft versus host disease in a premature infant. Arch Pathol Lab Med. 1980 Mar;104(3):141–144. [PubMed] [Google Scholar]
  23. Sloane J. P., Farthing M. J., Powles R. L. Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol. 1980 Apr;33(4):344–350. doi: 10.1136/jcp.33.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Storb R., Thomas E. D., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Goodell B. W., Sale G. E., Sanders J. E., Singer J. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med. 1980 Jan;92(1):30–36. doi: 10.7326/0003-4819-92-1-30. [DOI] [PubMed] [Google Scholar]
  25. Storb R., Thomas E. D., Buckner C. D., Clift R. A., Johnson F. L., Fefer A., Glucksberg H., Giblett E. R., Lerner K. G., Neiman P. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974 Feb;43(2):157–180. [PubMed] [Google Scholar]
  26. Sullivan K. M., Shulman H. M., Storb R., Weiden P. L., Witherspoon R. P., McDonald G. B., Schubert M. M., Atkinson K., Thomas E. D. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981 Feb;57(2):267–276. [PubMed] [Google Scholar]
  27. Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895–902. doi: 10.1056/NEJM197504242921706. [DOI] [PubMed] [Google Scholar]
  28. Wagemaker G., Vriesendorp H. M., van Bekkum D. W. Successful bone marrow transplantation across major histocompatibility barriers in rhesus monkeys. Transplant Proc. 1981 Mar;13(1 Pt 2):875–880. [PubMed] [Google Scholar]
  29. Weiden P. L., Flournoy N., Sanders J. E., Sullivan K. M., Thomas E. D. Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc. 1981 Mar;13(1 Pt 1):248–251. [PubMed] [Google Scholar]
  30. van Bekkum D. W., Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst. 1977 Mar;58(3):787–790. doi: 10.1093/jnci/58.3.787. [DOI] [PubMed] [Google Scholar]
  31. van Bekkum D. W., Roodenburg J., Heidt P. J., van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst. 1974 Feb;52(2):401–404. doi: 10.1093/jnci/52.2.401. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES